Vestibular Schwannoma Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Vestibular Schwannoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1Phase 2

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Vestibular Schwannoma
Akouos, Inc.27 enrolled4 locationsNCT06517888
Recruiting
Not Applicable

Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas

Vestibular Schwannoma
Medical College of Wisconsin36 enrolled1 locationNCT05702749
Recruiting
Not Applicable

Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma

Vestibular SchwannomaVestibular Schwannomas
Albert Torrents Torrero75 enrolled1 locationNCT07364955
Recruiting
Not Applicable

StableEyes With Active Neurofeedback

Vestibular DisorderVestibular SchwannomaSpace Motion Sickness
Johns Hopkins University48 enrolled2 locationsNCT05622344
Recruiting
Not Applicable

Early Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit

Vestibular SchwannomaUnilateral Vestibular Deficit
Hospices Civils de Lyon26 enrolled1 locationNCT06660082
Recruiting
Not Applicable

CI Following VS Removal or Labyrinthectomy

Vestibular SchwannomaMeniere Disease
Ohio State University15 enrolled1 locationNCT03795675
Recruiting

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma

OtotoxicityVestibular Schwannoma
University Hospital, Geneva258 enrolled1 locationNCT05641441
Recruiting

Intraoperative EABR for Decision Making

Hearing LossVestibular Schwannoma
Christoph Arnoldner15 enrolled1 locationNCT03745560
Recruiting

Cochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Results - a Pilot Study

Hearing LossVestibular Schwannoma
Christoph Arnoldner8 enrolled1 locationNCT03745534
Recruiting
Not Applicable

Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery

Vestibular SchwannomaNeurinoma, AcousticAcoustic Neuroma
Centre Hospitalier Universitaire de Besancon20 enrolled1 locationNCT06112509
Recruiting
Not Applicable

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Vestibular SchwannomaGlioma, Astrocytic
Northern Care Alliance NHS Foundation Trust17 enrolled1 locationNCT06572475
Recruiting
Not Applicable

Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma

Vestibular Schwannoma
University Hospital, Toulouse50 enrolled1 locationNCT04859335